The Chinese government approved Swiss drugmaker Roche's anti-inflammation drug Actemra to treat severe coronavirus symptoms.

TOP INSIGHT
When countries around the world are desperately searching for ways to combat 'Coronavirus', Actemra comes as an answer.
Read More..
Since Actemra’s approval a decade ago, it has become the go-to drug for inflammatory conditions, including cytokine storms in cancer patients receiving cell therapy.
The Swiss company, for which China is its No. 2 market behind the United States, is also making diagnostic gear to detect the coronavirus.
Currently, there is no published clinical trial data on the drug’s safety or efficacy against the virus.
More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany, and India.
MEDINDIA

Email










